A new study published in the journal Case Reports in Oncology, and published online by the National Institute of Health, has found that cannabis can treat acute lymphoblastic leukemia (ALL), a cancer of the white blood cells.
According to researchers; “Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells and is typically well treated with combination chemotherapy, with a remission state after 5 years of 94% in children and 30-40% in adults. This case study is on a 14-year-old patient diagnosed with a very aggressive form of ALL (positive for the Philadelphia chromosome mutation). A standard bone marrow transplant, aggressive chemotherapy and radiation therapy were revoked, with treatment being deemed a failure after 34 months.”
They continue; “Without any other solutions provided by conventional approaches aside from palliation, the family administered cannabinoid extracts orally to the patient. Cannabinoid resin extract is used as an effective treatment for ALL with a positive Philadelphia chromosome mutation and indications of dose-dependent disease control.”
Researchers conclude that; “The clinical observation in this study revealed a rapid dose-dependent correlation”, indicating that the higher the dose, the better the results.
The study can be viewed by clicking here.